Syschem
Syschem (SYSCHEM) share price was ₹36.62 at the 28 Oct 2026 close; market capitalisation ₹196 Cr; P/E (TTM) 25.79; sector Healthcare. The share price fell 32.9% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 0.1% year on year to ₹109.21 Cr and net profit was −₹1.67 Cr, against ₹1.67 Cr a year earlier (compared with Jun 2025). Promoters held 63.38% of Syschem in Sep 2026, up 3.23 percentage points from Jun 2026. Its Tapetide Score is 51/100 (Average) as of 28 Oct 2026.
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,766.50 | 35.04 | 4,23,843 Cr | 5.07 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,631.00 | 87.41 | 2,55,673 Cr | 15.25 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,596.50 | 72.16 | 1,74,836 Cr | 9.52 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,183.50 | 107.88 | 1,17,977 Cr | 22.26 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,180.90 | 26.28 | 1,17,795 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,340.80 | 34.73 | 1,11,914 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,370.80 | 32.84 | 1,10,741 Cr | 3.13 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| Syschem (this company) | — | 25.79 | 196 Cr | 1.41 | 0.00% | 8.93% | 13.25% | 584 Cr | 6 Cr |
| Median 8 companies | ₹1,766.50 | 34.89 | 1,17,886 Cr | 4.71 | 0.47% | 12.98% | 16.41% | 22,787 Cr | 3,055 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 100/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
6- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 32.4% CAGR over last 5 years
- Promoter holding has increased by 2.52% over last quarter.
- Company's median sales growth is 70.0% of last 10 years
- Company's working capital requirements have reduced from 40.8 days to 29.3 days
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 6.41% over last 3 years.
Technical Indicators
Oscillators
Bearish
Overall
Neutral
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
change over 1 year Operating margin 0.49% · Jun 2026
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 43.1 | 37.11 | 43.74 | 74.71 | 87.53 | 47.52 | 77.76 | 119 | 109 | 104 | 142 | 219 | 109 |
| Expenses | 40.65 | 35.26 | 42.66 | 73.09 | 86.72 | 47.45 | 76.56 | 117 | 107 | 100 | 136 | 210 | 109 |
| Operating Profit | 2.45 | 1.85 | 1.08 | 1.62 | 0.81 | 0.07 | 1.2 | 1.9 | 2.46 | 3.3 | 5.96 | 9.37 | 0.54 |
| OPM % | 5.68% | 4.99% | 2.47% | 2.17% | 0.93% | 0.15% | 1.54% | 1.6% | 2.25% | 3.19% | 4.21% | 4.27% | 0.49% |
| Other Income | 0 | 0 | 0.01 | 0.15 | 0.01 | 0 | 0.02 | 0.02 | 0.01 | 0.01 | 0 | 0 | 0.05 |
| Interest | 0.1 | 0.03 | 0.11 | 0.01 | 0 | 0.03 | 0.04 | 0 | 0.04 | 0.01 | 0.17 | 2.04 | 0.49 |
| Depreciation | 0.68 | 0.7 | 0.74 | 0.67 | 0.68 | 0.68 | 0.68 | 0.91 | 0.76 | 0.76 | 0.82 | 1.73 | 1.56 |
| PBT | 1.67 | 1.12 | 0.24 | 1.09 | 0.14 | -0.64 | 0.5 | 1.01 | 1.67 | 2.54 | 4.97 | 5.6 | -1.46 |
| Tax % | 0% | 0% | 0% | 123.85% | 0% | 0% | 0% | 54.46% | 0% | 25.59% | 15.9% | 68.93% | 15.07% |
| Net Profit | 1.68 | 1.12 | 0.23 | -0.26 | 0.14 | -0.64 | 0.5 | 0.46 | 1.67 | 1.9 | 4.17 | 1.74 | -1.67 |
| EPS (₹) | 0.42 | 0.28 | 0.06 | -0.07 | 0.04 | -0.16 | 0.13 | 0.11 | 0.38 | 0.44 | 0.96 | 0.36 | -0.34 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11 | 4 | 13 | 67 | 93 | 77 | 68 | 59 | 114 | 199 | 332 | 574 | 574 |
| Expenses | 14 | 5 | 12 | 63 | 89 | 77 | 73 | 58 | 105 | 192 | 328 | 553 | 554 |
| Operating Profit | -3 | -1 | 0 | 3 | 4 | 0 | -5 | 1 | 9 | 7 | 4 | 21 | 19 |
| OPM % | -23% | -24% | 0.4% | 4.5% | 4.4% | -0.1% | -7% | 0.9% | 8% | 3.5% | 1.2% | 3.7% | 3.3% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 5 |
| PBT | -5 | -3 | -2 | 1 | 2 | -2 | -7 | -2 | 6 | 4 | 1 | 15 | 12 |
| Tax % | -26% | -27% | -30% | 43% | 50% | -16% | -24% | -22% | 27% | 33% | 54% | 26% | — |
| Net Profit | -4 | -2 | -1 | 0 | 1 | -2 | -6 | -2 | 5 | 3 | 0 | 11 | 6 |
| EPS (₹) | -1.94 | -1.13 | -0.75 | 0.17 | 0.32 | -0.79 | -2.07 | -0.59 | 1.13 | 0.69 | 0.11 | 2.23 | 1.42 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 19 | 19 | 22 | 23 | 32 | 40 | 44 | 49 |
| Reserves | -6 | -8 | -10 | -8 | -8 | -10 | -15 | -16 | -10 | 17 | 48 | 73 |
| Borrowings | 28 | 27 | 22 | 20 | 16 | 17 | 16 | 2 | 2 | 0 | 0 | 0 |
| Other Liabilities | 13 | 12 | 16 | 29 | 35 | 36 | 55 | 51 | 69 | 107 | 126 | 169 |
| Total Liabilities | 51 | 47 | 44 | 58 | 62 | 62 | 77 | 60 | 93 | 164 | 217 | 292 |
| Fixed Assets | 34 | 32 | 30 | 29 | 27 | 28 | 30 | 32 | 31 | 31 | 53 | 68 |
| CWIP | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 4 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 16 | 15 | 14 | 28 | 35 | 34 | 46 | 28 | 62 | 129 | 164 | 224 |
| Total Assets | 51 | 47 | 44 | 58 | 62 | 62 | 77 | 60 | 93 | 164 | 217 | 292 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1 | 0 | 6 | 0 | -2 | 3 | 4 | 1 | -8 | -26 | -10 | 8 |
| Investing | 0 | 0 | 0 | 0 | 2 | -4 | -4 | -1 | -2 | -6 | -22 | -20 |
| Financing | -2 | -1 | -7 | 0 | 0 | 0 | 0 | 0 | 11 | 32 | 34 | 18 |
| Net Cash Flow | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 6 |
| Free Cash Flow | 1 | 0 | 6 | -1 | -2 | 0 | -1 | -2 | -10 | -32 | -32 | -11 |
| CFO/OP | -56 | -53 | 12,760 | 9 | -24 | -3,456 | -40 | 107 | -79 | -348 | -238 | 54 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 187 | 272 | 124 | 47 | 21 | 47 | 31 | 21 | 135 | 126 | 99 | 92 |
| Inventory Days | 228 | 868 | 182 | 80 | 104 | 110 | 199 | 152 | 61 | 107 | 81 | 41 |
| Days Payable | 290 | 870 | 424 | 151 | 131 | 175 | 221 | 186 | 158 | 198 | 143 | 112 |
| Cash Conversion Cycle | 124 | 271 | -119 | -24 | -7 | -19 | 9 | -14 | 38 | 34 | 36 | 21 |
| Working Capital Days | -139 | -564 | -319 | -50 | -20 | -36 | -1 | -15 | 48 | 54 | 39 | 29 |
| ROCE % | -11% | -8% | -6% | 3% | 7% | -8% | -29% | -12% | 38% | 11% | 1% | 16% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Syschem insights
66 extracted metrics + investor summaries across FY10–FY27.
Documents
Frequently Asked Questions about Syschem
What does Syschem (India) Ltd do?
Where is Syschem (India) Ltd (SYSCHEM) listed?
Which sector does Syschem (India) Ltd belong to?
What is the market capitalisation of Syschem (India) Ltd?
What is the PE ratio of Syschem (India) Ltd?
What is the 52-week high and low of Syschem (India) Ltd?
What is the Return on Equity (ROE) of Syschem (India) Ltd?
Company Information
Incorporated in 1993, Syschem (India) Limited manufactures Active Pharmaceuticals Ingredients (APIs) and bulk drugs.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531173.md for Syschem (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.